Emma Johnson
Board Member | London, England, United Kingdom
Professional Overview
Emma Johnson is an experienced investment professional with a focus on the life sciences sector. As a Senior Investment Manager at the British Business Bank, she oversees a portfolio of investments in early-stage biotechnology and pharmaceutical companies. Emma also serves on the boards of several leading life sciences firms, providing strategic guidance and oversight to drive innovation and growth.
Experience Summary
Current Roles
- Board Member, Maxion Therapeutics (2025-02-01 to Present)
- Board Observer, OMass Therapeutics (2024-10-01 to Present)
- Board Observer, Purespring Therapeutics (2024-09-01 to Present)
- Board Member, Tenpoint Therapeutics Ltd (2022-11-01 to Present)
- Senior Investment Manager (Life Sciences), British Business Bank (2023-04-01 to Present)
In her role as Senior Investment Manager, Emma is responsible for identifying and evaluating promising life sciences investment opportunities, managing a portfolio of high-potential investments, and providing strategic guidance to portfolio companies. She has played a key role in securing substantial funding for several groundbreaking biotechnology and pharmaceutical startups, driving their growth and innovation.
Career Progression
Prior to her current position, Emma held investment roles at Catapult Ventures Group, where she progressed from Investment Analyst to Investment Associate, evaluating and supporting early-stage life sciences companies. She has also gained valuable experience through internships at McCann Health and the Institute of Cognitive Neuroscience at University College London.
Academic Background
Emma holds a degree in Neuroscience from the University of Cambridge, where she graduated with Honors. Her academic focus on cognitive neuroscience has provided her with a deep understanding of the life sciences industry and the complex challenges facing the sector.
Areas of Expertise
- Life sciences investments and portfolio management
- Early-stage biotechnology and pharmaceutical company evaluation
- Strategic planning and board-level advisory
- Venture capital and private equity investment
- Regulatory and scientific landscape in the life sciences industry
Professional Impact
Throughout her career, Emma has demonstrated a keen ability to identify and support promising life sciences startups, helping them to secure critical funding and navigate the complex regulatory environment. Her contributions have played a pivotal role in advancing the development of innovative therapies and technologies that are poised to have a significant impact on patient outcomes.
Conclusion
With her extensive experience in the life sciences investment space, Emma Johnson is a respected and influential figure in the industry. Her strategic guidance and investment acumen have been instrumental in fostering the growth and success of numerous biotechnology and pharmaceutical companies, positioning her as a valuable asset to the organizations she serves.
